Tofacitinib for Immune Skin Conditions in Down Syndrome

NCT04246372 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Down Syndrome
Alopecia Areata
Atopic Dermatitis / Eczema
Hidradenitis Suppurativa
Vitiligo
Psoriasis

Interventions

DRUG: Tofacitinib

Sponsor

University of Colorado, Denver

Collaborators

[object Object]